DEGENERATIVE ENCEPHALOPATHY RESEARCH GROUP
The Charity aims to benefit the public by funding, undertaking, furthering and publishing biomedical research to determine the molecular causes and facilitate the early diagnosis, therapy and prevention of the group of transmissible degenerative diseases of the central nervous system of which CJD in humans and scrapie in animals are examples and of similar diseases not known to be transmissible.
Objects
TO BENEFIT THE PUBLIC BY FUNDING, UNDERTAKING, FURTHERING AND PUBLISHING BIOMEDICAL RESEARCH TO DETERMINE THE MOLECULAR CAUSES AND FACILITATE THE EARLY DIAGNOSIS, THERAPY AND PREVENTION OF THE GROUP OF TRANSMISSIBLE DEGENERATIVE DISEASES OF THE CENTRAL NERVOUS SYSTEM OF WHICH CREUZFELDT JAKOB DISEASE (CJD) IN HUMANS AND SCRAPIE IN ANIMALS ARE EXAMPLES AND OF SIMILAR DISEASES NOT KNOWN TO BE TRANSMISSIBLE OF WHICH ALZHEIMER'S DEMENTIA AND PARKINSON'S DISEASE ARE HUMAN EXAMPLES..
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
- David Ivor Bradley Body
- Dr ANNE CATHERINE MADDOCKS
- PETER MILLS
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 28/02/2025 | £11k | £4k |
| 29/02/2024 | £5k | £688 |
| 28/02/2023 | £1k | £506 |
| 28/02/2022 | £211 | £470 |
| 28/02/2021 | £791 | £469 |